L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH.
Open Access
- 1 December 1988
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 82 (6) , 1915-1921
- https://doi.org/10.1172/jci113810
Abstract
Nodular sclerosing Hodgkin's disease is characterized by dense collagen fibrosis. Although transforming growth factor-beta (TGF-beta) is an important bifunctional growth factor for fibroblasts and is stored and released by many cells, it requires acidification to pH 2.0-3.0 before it becomes a biologically active growth factor. We show here that the L-428 Hodgkin's cell releases a high molecular weight TGF that competes for the TGF-beta cell membrane receptor but not the TGF-alpha receptor. This growth factor is most active at physiologic pH and is 97% inactivated by acidification. Hodgkin's TGF is also inactivated by proteases and can be preserved by protease inhibitors. The Hodgkin's TGF can be separated from an autocrine growth factor using either column chromatography or electroelution from gels and is shown to have a molecular weight of approximately 350,000. Incubation of the Hodgkin's TGF in SDS releases a 25,000-D protein with reduced biological activity but which cross-reacts with anti-TGF-beta IgG. We propose that L-428 nodular sclerosing Hodgkin's disease fibrosis is mediated by a potent high molecular weight TGF-beta which, unlike TGF-beta characterized to date, is secreted in a form most active at physiologic pH.This publication has 32 references indexed in Scilit:
- Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.Published by Elsevier ,2021
- TRANSFORMING GROWTH-FACTORS PRODUCED BY NORMAL AND NEOPLASTICALLY TRANSFORMED RAT-LIVER EPITHELIAL-CELLS IN CULTURE1988
- Transforming growth factors from neoplastic and nonneoplastic tissues.1983
- Serum contains a platelet-derived transforming growth factor.Proceedings of the National Academy of Sciences, 1982
- Characteristics of Hodgkin's disease-derived cell lines.1982
- POTENTIATION OF FIBROBLAST GROWTH BY NODULAR SCLEROSING HODGKINS-DISEASE CELL-CULTURES1982
- TRANSFORMING GROWTH-FACTOR PRODUCTION BY CHEMICALLY TRANSFORMED-CELLS1981
- Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction.Proceedings of the National Academy of Sciences, 1980
- Growth factors from murine sarcoma virus-transformed cells.Proceedings of the National Academy of Sciences, 1978
- PATHOLOGY AND NOMENCLATURE OF HODGKINS DISEASE1966